# Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

> **NCT00003870** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** methotrexate
- **PROCEDURE:** allogeneic bone marrow transplantation
- **RADIATION:** iodine I 131 monoclonal antibody BC8
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003870
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** 2001-11
- **Final completion:** 2001-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003870, "Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*